PTPRC and neoplasm: In a recent review paper [7], increasing proportion of immune cells (identified with surface markers including CD45 and CD68), secretion of inflammatory cytokines (including IL-1, IL-6, TNF), and activation of key regulatory signaling networks such as NF-kB have been associated with tumour proliferation.